VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Thursday, January 8, 2026
Stock Comparison
Industria de Diseno Textil, S.A. vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Industria de Diseno Textil, S.A.
ITX · Bolsa de Madrid
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Industria de Diseno Textil, S.A.'s moat claims, evidence, and risks.
View ITX analysisSanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Sanofi leads (74 / 100 vs 69 / 100 for Industria de Diseno Textil, S.A.).
- Segment focus: Industria de Diseno Textil, S.A. has 3 segments (71.9% in Zara / Zara Home); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Moderate vs Moderate.
- Moat breadth: Industria de Diseno Textil, S.A. has 4 moat types across 3 domains; Sanofi has 5 across 3.
Primary market context
Industria de Diseno Textil, S.A.
Zara / Zara Home
Fast-fashion apparel and home goods retail (Zara and Zara Home)
Global
Consumers (end-users) via owned stores and e-commerce
Brand owner + omnichannel retailer
71.9%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
Industria de Diseno Textil, S.A. strengths
Sanofi strengths
Segment mix
Industria de Diseno Textil, S.A. segments
Full profile >Zara / Zara Home
Competitive
Bershka
Competitive
Other Concepts (Pull&Bear, Massimo Dutti, Stradivarius, Oysho)
Competitive
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.